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Summary: Common problems in ill returned travelers to Brazil are dermatologic conditions, 
diarrhea, and febrile illnesses, especially dengue. Travelers to mass events in Brazil will confront 
multiple challenges. Knowledge of these risks can help clinicians to advise travelers and care for 
those who become ill.  
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Abstract:  
Background: Brazil will host the 2014 FIFA World Cup and the 2016 Olympic and Paralympic 
Games, events that are expected to attract hundreds of thousands of international travelers. 
Travelers to Brazil will encounter locally endemic infections as well as mass-event-specific 
risks.  
Methods: We describe 1586 ill returned travelers who had visited Brazil and were seen at a 
GeoSentinel Clinic from July 1997 through May 2013. 
Results: The most common travel-related illnesses were dermatologic conditions (40%), 
diarrheal syndromes (25%), and febrile systemic illness (19%). The most common specific 
dermatologic diagnoses were cutaneous larva migrans, myiasis, and tungiasis. Dengue and 
malaria, predominantly Plasmodium vivax, were the most frequently identified specific causes of 
fever and the most common reasons for hospitalization after travel. Dengue fever diagnoses 
displayed marked seasonality, although cases were seen throughout the year. Among the 28 ill 
returned travelers with HIV infection, 11 had newly diagnosed asymptomatic infection and 9 had 
acute symptomatic HIV. 
Conclusions: Our analysis primarily identified infectious diseases among travelers to Brazil. 
Knowledge of illness in travelers returning from Brazil can assist clinicians to advise prospective 
travelers and guide pre-travel preparation, including itinerary-tailored advice, vaccines and 
chemoprophylaxis; it can also help to focus post-travel evaluation of ill returned travelers. 
Travelers planning to attend mass events will encounter other risks that are not captured in our 
surveillance network.  
Ac
ce
pte
d M
an
us
cri
pt
4 
 
Brazil will host the 2014 FIFA World Cup and the 2016 Olympic and Paralympic Games. These 
events will attract participants and spectators from around the globe. The FIFA World Cup, to be 
held from June 12 through July 14, 2014 in 12 cities (Figure 1), is expected to draw an estimated 
600,000 international tourists and 3 million domestic travelers [1].  The Brazil Olympic Games, 
which will take place mainly in Rio de Janeiro, will be held August 5-21, 2016, followed by the 
summer Paralympics, September 7-18 [2].  Based on data from the 2012 Olympics in London, 
the 2016 Olympic Games and Paralympics are expected to attract 600,000 international visitors, 
including 15,000-17,000 athletes [3].  
Brazil is a large country with abundant natural resources and varied terrain, including the 
Amazon basin and tropical rain forests. In Rio de Janeiro alone, one can find beaches, 
mountains, a rain forest, a lagoon, and slums (favelas). Although the sports events will be held at 
specific venues, travelers to these events may also visit other parts of Brazil. 
Brazil has made great progress over the last three decades in providing safe water, improved 
sanitary facilities and access to health care, including vaccination and HIV treatment [4]. 
However, attendees of these sports events will potentially be at risk for health problems, both 
infectious and non-communicable, and exacerbation of chronic diseases.  Non-communicable 
health risks include intentional and unintentional injuries that can be caused by violence and 
mass gatherings, and environmental stressors. Infectious diseases include locally endemic 
infections as well as widely distributed infections, such as influenza and sexually transmitted 
infections.  Risk for the latter may be heightened during mass gatherings [5].  
Deaths from infectious diseases in Brazil have dropped dramatically since 1980 [4], yet malaria 
and yellow fever (YF) remain endemic in parts of the country (Figure 1). Dengue has caused 
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recent massive urban outbreaks; HIV/AIDS is widespread; leishmaniasis and schistosomiasis are 
present in focal areas [6, 7]. 
In anticipation of increased travel to Brazil, we have analyzed data collected by the GeoSentinel 
Surveillance Network about illness in travelers returned from Brazil. Knowledge of these 
illnesses can inform health providers about specific risks and guide pre-travel preparation; it can 
also help to focus post-travel evaluation of ill returned travelers. Our data describe primarily 
infectious diseases and understate the frequency of injury, which may be a greater risk to those 
attending mass events [8]. 
Methods 
The GeoSentinel Surveillance Network (www.istm.org/geosentinel) [9] is an international 
network of specialized travel and tropical medicine clinics located on six continents. All sites 
collect data by using a standard reporting form on ill travelers seen during or after international 
travel. Anonymized data on demographics, travel history, reason for travel, pre-travel advice, 
hospitalization, major clinical symptoms and final diagnoses assigned by the GeoSentinel site 
clinician are electronically entered into a central database. Diagnoses are selected from a 
standard list of over 500 diagnostic codes, and involve syndromic groupings alone if no etiology 
is defined or syndromic groupings plus specific etiologies where possible. Individual patients can 
have more than one final diagnosis.  All sites use the best reference diagnostic tests available in 
their own country. Country of exposure is identified by the clinician based on the travelers’ 
itinerary, known endemicity patterns of the destinations visited and incubation period of the 
illness.  
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This evaluation includes ill travelers who were seen after travel at a GeoSentinel site from July 
1997 through May 2013, with Brazil declared as the single country of exposure; travelers with 
another country of exposure stated along with Brazil were excluded. Those traveling for 
immigration were also excluded. Final diagnoses were included if they had been classified as 
confirmed or probable.  Demographic and travel characteristics of ill travelers returning from 
Brazil were described by using frequencies and proportions for categorical variables and median 
and range for continuous variables. Analysis of illness trends over time was based on monthly 
counts of ill returned travelers aggregated over the entire study period for dengue. Because the 
World Cup and Olympic Games will take place during the cooler months in Brazil, we 
specifically examined and aggregated top diagnoses reported during June through September. 
Numbers of dengue cases per month in Brazil during 2008 -2012 are from the Brazilian Ministry 
of Health [link: 
http://dtr2004.saude.gov.br/sinanweb/tabnet/dh?sinannet/dengue/bases/denguebrnet.def]. All data 
analysis was performed by using SAS v. 9.2 (Cary, NC).  
Results  
Table 1 shows the demographic and trip characteristics of 1586 ill-returned travelers to Brazil. A 
majority of these travelers were male (55%), and they were often traveling for tourism (65%). 
Only 50% sought pre-travel advice. Trip duration was <30 days for 59%. Of those who traveled 
to Brazil, 233 (15%) traveled to other countries within the 6 months before their clinic visit date. 
Top syndromic diagnoses in ill returned travelers (Table 2) were dermatologic (40%), diarrheal 
syndromes (25%), and febrile systemic illness (19%). The most frequent specific dermatologic 
diagnoses were cutaneous parasitic infections including cutaneous larva migrans (CLM), 
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myiasis, and tungiasis; skin and soft tissue infections were also observed (Table 2). CLM was the 
most common diagnosis during June, July, and September (Table 3).  
Among those with both acute and chronic diarrheal syndromes, no specific pathogen was 
identified for >50%. Campylobacter, the bacterial GI pathogen most often identified, was found 
in 4%; giardiasis was diagnosed in 9%. Intestinal strongyloidiasis was diagnosed in 15 and 
hyperinfection syndrome in 1; schistosomiasis was diagnosed in 11. 
Among 297 diagnoses of systemic febrile illness were 92 (31%) diagnoses of dengue fever and 
25 (8%) diagnoses of malaria, 20 of them Plasmodium vivax (two each P. falciparum and 
malaria species unknown, and one P. ovale).  There were 17 diagnoses of Epstein-Barr 
virus/mononucleosis, 7 of cytomegalovirus, and 17 of influenza-like illness (2 confirmed).   
Figure 2 shows the number of dengue fever diagnoses according to month for 2008 through 
2012. Table 3 shows top diagnoses during the cooler months in Brazil, when fewer dengue 
infections were seen.  
Dengue and malaria were the most common diagnoses leading to hospitalization, recorded for 
20% of dengue and 64% of malaria patients. Infrequently diagnosed infections in ill returned 
travelers to Brazil included rickettsial infections (3), histoplasmosis (3), visceral leishmaniasis 
(1), and leptospirosis (1). No deaths were recorded. 
Although it was not one of the top diagnoses, HIV infection was found in 28 ill returned 
travelers, including three with AIDS. Eleven had newly diagnosed asymptomatic infection and 9 
acute symptomatic HIV. Among other sexually transmitted infections, syphilis was reported in 3, 
urethritis 3, lymphogranuloma venereum 1, and sexually transmitted infection (undefined) 1.  
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No cases of measles, mumps, rubella, pertussis, acute hepatitis B, or yellow fever were reported, 
and most vaccine-preventable infections, except for influenza, were infrequent or not observed. 
Four cases of enteric fever (2 typhoid; 2 paratyphoid fever) and 4 hepatitis A cases were 
reported. Seventeen returned travelers were seen for rabies post-exposure prophylaxis; 
specifically reported exposures were dogs (7), monkeys (3), and a cat (1). 
Discussion 
Mass gatherings entail a series of event-specific, individual health risks. In the past, many 
injuries and casualties have been attributable to stampedes and crush injuries, violence, crime 
and even terrorist attacks, traffic accidents, and trauma associated with drug and alcohol 
intoxication [8]. Emotional stress, aggression and cardiovascular events, may be a heightened 
risk, in particular during sports events, as well as outdoor activity-specific health risks such as 
sunburn, heatstroke or dehydration [8]. While weather and environmental factors cannot be 
altered and many preventive and pre-emptive measures have to be organized by local authorities, 
many of the above-listed health risks can be, at least partly, controlled by the individual (e.g. 
using sun protection, continuous rehydration, and avoiding dangerous areas and excess alcohol 
consumption). Pre-travel preparation should include education about these risks.  
Travelers to Brazil may encounter Brazil-endemic infections as well as mass event-related 
problems. Based on GeoSentinel data, we have identified dermatologic problems, diarrhea, and 
febrile systemic infections (especially dengue) as the most common diagnoses in returned 
travelers from Brazil.  Dengue fever and malaria were the most common reasons for 
hospitalization.  
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Skin problems accounted for 40% of diagnoses in ill returned travelers. The most common 
diagnosis, CLM, was found in 11%.  The etiologic agents of CLM are common in Brazil [10]. 
Almost 90% of dogs and 94.2% of cats in Adrandina Municipality, Sao Paulo were infected with 
Ancylostoma caninum and A. brasiliense [11]. Thirty percent of beach sand samples from Alto 
Beach, Pernambuco (near Recife) contained larvae of these organisms [12]. Most travelers 
acquire infection during beach exposures. Many popular tourist destinations and sites for the 
sports events, such as Rio de Janeiro, Salvador, Recife, and Fortaleza have coastal locations. 
Hookworm larvae in sand and soil penetrate the dermis and migrate superficially, causing 
migrating linear, serpiginous tracks accompanied by severe pruritus [13] [Figure 3]. The feet are 
most often affected (39%), followed by the buttocks and abdomen. Infection may persist weeks 
to months, rarely up to a year.  Oral albendazole or ivermectin provides safe, effective treatment 
[14, 15]. Prevention is by avoidance of skin contact with soil/sand. 
Myiasis and tungiasis each accounted for more than 2% of diagnoses in ill returned travelers. 
Furuncular myiasis is a skin infection with the larva of a diptera fly, most frequently 
Dermatobium hominis [16]. The adult fly lays its eggs on the under-belly of a mosquito that 
subsequently feeds on humans. The eggs lodge in the dermis and develop to the 3rd stage larva 
over 1-5 months, manifesting as a small papule that enlarges to a tender nodule with a central 
punctum through which serosanguinous fluid drains [Figure 4]. Treatment is by suffocation and 
removal of the larva [17]; prevention is by use of insect repellents and/or wearing long sleeves 
and trousers during the day. 
Tungiasis, caused by penetration of the epidermis by the female sand fly Tunga penetrans and 
related species, can occur virtually anywhere on the skin, although >97% are found on the feet 
[18,19]. Black papules at the site of penetration develop into nodules with a pale halo. Treatment 
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is removal of the flea [20] [Figure 5]; prevention is by the use of closed toed footwear and 
avoidance of skin contact with soil. 
Cutaneous leishmaniasis was seen infrequently in travelers returned from Brazil, although it 
remains a public health problem in focal areas (>20,000 new cases reported annually in Brazil) 
[22]; visceral leishmaniasis is a growing problem [4]. Travelers should be advised to reduce bites 
from sandflies, whose bite transmits infection, by using insect repellents and/or long-sleeved 
shirts and trousers during evening hours in endemic regions. 
Given the frequency of both acute and chronic diarrheal syndromes among ill travelers returning 
from Brazil, food and water precautions are recommended. Clinicians may provide symptomatic 
antidiarrheal agents and antibiotics for presumptive self-treatment should diarrhea develop (e.g. 
loperamide plus quinolone/ or azithromycin for bacterial pathogens). 
Dengue, the most frequent specified cause of systemic febrile illness, was reported in almost 6% 
of ill returned travelers; 20% were hospitalized. Cases occurred throughout the year (Figure 2). 
Since 1986 dengue in Brazil has increased in incidence and severity [22]. Massive epidemics 
have affected urban centers, including Rio de Janeiro and Sao Paulo [23, 23]; 3.5 million cases 
were reported during 2000-2009. Three dengue serotypes, DENV-1, DENV-2, and DENV-3 
circulate widely in Brazil; DENV-4 has caused recent outbreaks [24]. Transmission is most 
intense during February through June. The day-biting main mosquito vector, Aedes aegypti, is 
widespread in urban areas.  The primary way to avoid infection is to prevent mosquito bites with 
repellent on exposed skin. Only travelers to certain areas of Brazil will be at risk for malaria, but 
travelers to all areas will be at risk for dengue.   
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Malaria transmission persists in the Brazilian Amazon region (Figure 1); about 300,000 cases are 
reported annually, with P. vivax accounting for >80% and P. falciparum <20% of cases. 
GeoSentinel cases reflect these proportions. Travelers who will visit malaria-endemic areas can 
be protected with chemoprophylaxis [25]. Some non-US guidelines recommend standby 
emergency treatment as an alternative. 
No cases of yellow fever were recorded among 1586 ill returned travelers to Brazil; however, 
cases still occur in Brazil despite vaccination programs. From 1973 through 2008, among the 831 
notified cases of YF in Brazil, mortality was 51%. Groups most affected were migrant laborers, 
farm workers, and tourists [26]. In recent years, the Brazil Ministry of Health has expanded the 
areas for which YF vaccination is recommended. Vaccination is not recommended for travel to 
the large eastern cities of Rio de Janeiro, Sao Paulo, Salvador, Recife, and Fortaleza, but is 
recommended for several cities hosting World Cup events, including Belo Horizonte, Brasilia, 
and Manaus (Figure 1). Urban areas in Brazil are infested with mosquitoes competent to transmit 
YF virus [27]. Brazil has reported to WHO that no YF vaccine is required for entry, but 
conflicting information has been provided by some Brazilian authorities.  Travelers should check 
their entry requirement with Brazilian authorities in their own countries as well as the Brazil 
Ministry of Health.  
Travel is a risk factor for sexually transmitted infections (STIs). An estimated 20-50% of 
travellers have casual sex [28, 29]. Approximately half of travel-related sex is unsafe sex [28]. 
Isolation from family and removal of inhibitions because of anonymity and/or alcohol may 
contribute to sexual behavior during travel. Among ill travelers who consulted a GeoSentinel 
site, 0.9% were diagnosed with a travel-related STI [30]. HIV infections, including acute HIV, 
were reported in 28 returned travelers, including three with AIDS, and possibly others infected 
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before their recent trip. In Brazil, an estimated 600,000 people are HIV-infected (mean national 
seroprevalence <0.6%); about 33,000 new infections are reported yearly [4]. Travelers should be 
reminded to avoid unsafe sexual practices and exposure to potentially contaminated needles and 
blood.  
The absence of the vaccine-preventable infections measles, rubella, mumps, or pertussis may 
reflect the high rates of vaccine coverage in Brazil or high coverage in travelers to Brazil. 
Measles was eliminated from Brazil in 1999. However, travelers should be up to date with these 
vaccinations; during mass events they will have contact with visitors from measles-endemic 
countries. Airborne transmission of measles occurred in a domed stadium and other venues 
during the International Special Olympic Games in 1991 [31]. Superspreading events can rapidly 
lead to large epidemics [32]. Measles and mumps outbreaks have also followed other mass 
gatherings [33, 34]. After the Winter Olympic Games in Vancouver (February 2010), a measles 
outbreak occurred with 82 confirmed cases [35]. Other vaccine-preventable infections, including 
typhoid fever, hepatitis A, and acute hepatitis B, were infrequent or absent in ill returned 
travelers, possibly reflecting improved sanitation and access to health care in Brazil [4] and pre-
travel immunization. Hepatitis A vaccine is still recommended for most travelers to Brazil. 
 
The close interaction of large numbers of people from all over the world can facilitate 
transmission of infections spread from person to person, such as norovirus (outbreaks during 
2006 World Cup) and influenza [5, 36, 37]. Although few cases of influenza were reported in our 
data, during mass gatherings influenza may have greater prominence. During the Salt Lake City 
winter games 316 (12%) of the 2,635 clinic visits were for respiratory illness, and 188 (59%) 
were diagnosed with influenza-like illness. Thirty-six had confirmed influenza; 36% of these 
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were in athletes [37]. Surveillance of illnesses at six Beijing clinics during the 2008 Olympic and 
Paralympic Games found that the most common diagnoses for foreign visitors were respiratory, 
injury/musculoskeletal, and gastrointestinal illnesses [38]. 
The World Cup and Olympic Games will take place during Brazil’s winter season. An analysis 
of influenza-associated excess mortality data from Brazil for the period 1980-2008 showed no 
clear seasonality in northern, tropical Brazil. In Southern Brazil (location of most sports events; 
Figure 1), 73.5% of 627 influenza viruses identified through routine surveillance (2000-2008) 
were detected during April to August, and influenza showed clear seasonality, peaking in June 
and July [39].  
Influenza vaccine is recommended with the vaccine produced for the Southern Hemisphere, but 
if that is not available, then pre-travel vaccination with the Northern Hemisphere strains should 
be considered. Influenza outbreaks can spread rapidly during mass events, and returning travelers 
aid global virus dispersal [40].  
Limitations 
These results reflect sentinel surveillance data among ill returned travelers visiting specialist 
(GeoSentinel) clinics and are not representative of all ill returned travelers. Individuals traveling 
to the World Cup or Olympic events may have a different spectrum of illnesses. Those with mild 
or self-limited illnesses may not seek care or may see their primary care provider. People do not 
seek care for injuries or STIs at a GeoSentinel clinic. Hospitalized patients may not be captured 
in the database. Denominators including travelers who remained healthy are lacking, so the 
incidence of illness in travelers cannot be calculated.  Additionally, immunization status and use 
of malaria chemoprophylaxis are unknown. In only 10% of diagnoses was the probable location 
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of illness acquisition within Brazilrecorded, too small to derive meaningful conclusions about 
regional differences. Finally, this analysis is based on past events. Future risks could be different, 
including potential disrupters, such as chikungunya virus, a novel coronavirus, and new 
influenza viruses. Although local transmission of chikungunya virus has not been reported in 
Brazil, competent vectors are present [41]. Since December 2013, local transmission has been 
reported in the Caribbean   [42]. Introduction into Brazil is a potential risk with large numbers of 
visitors from areas  with ongoing chikungunya virus transmission [43].  
Although this paper highlights risks for travelers to mass sports events, the findings are also 
relevant to those traveling to Brazil for other reasons and at other times. Preparation for Brazil 
travel involves reviewing the itinerary for potential need for YF vaccination and malaria 
chemoprophylaxis. Influenza vaccination, if available, would be prudent for those visiting during 
May-August, especially for those attending mass events. Travelers should be reminded about 
avoiding bloodborne infections and STIs, including HIV. Education about avoiding food and 
waterborne infections, vectorborne infections, and CLM and other common skin infections 
should be part of the preparation for all travelers. The findings in this analysis also will be 
helpful to clinicians caring for ill-returned travelers from Brazil by providing data about more 
and less common diagnoses and directing them to useful resources.   
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Liverpool School of Tropical Medicine, Liverpool, UK; Alejandra Gurtman, Mount Sinai 
Medical Center, New York City, New York, USA (Oct. 2002 – Aug. 2005 only); Susan 
McLellan; Tulane University, New Orleans, Louisiana, USA (Dec. 1999 – Aug. 2005 only); 
Elizabeth D. Barnett, Boston University, Boston, Massachusetts, USA; Stefan Hagmann, 
Michael Henry, and Andy O. Miller, Bronx-Lebanon Hospital Center, Bronx, New York, USA; 
Marc Mendelson and Peter Vincent, University of Cape Town and Tokai Medicross Travel 
Clinic, Cape Town, South Africa; Michael W. Lynch, Fresno International Travel Medical 
Center, Fresno, California, USA (Aug. 2003 – Feb. 2010 only); Phi Truong Hoang Phu, Nicole 
Anderson, Trish Batchelor, and Dominique Meisch, International SOS Clinic, Ho Chi Minh City, 
Vietnam; Johnnie Yates and Vernon Ansdell, Kaiser Permanente, Honolulu, Hawaii, USA (Oct. 
1997 - Jan. 2003 only); Prativa Pandey, Rashila Pradhan, and Holly Murphy, CIWEC Clinic 
Travel Medicine Center, Kathmandu, Nepal; Filipe Basto and Candida Abreu, Hospital de São 
João, Porto, Portugal. 
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Figure 1: Map of Brazil (includes shading for yellow fever and malaria and all major cities where 
World Cup and Olympic and Paralympic Games will be held).  Sources: http://cdc‐
malaria.ncsa.uiuc.edu, http://wwwnc.cdc.gov/travel/pdf/yellow‐fever‐vacc‐brazil.pdf, 
http://www.rio2016.org/en/the‐games/maps/venues‐map, 
http://www.fifa.com/worldcup/destination/cities/index.html  
Figure 2: Dengue fever diagnoses of ill returned travelers exposed in Brazil seen at GeoSentinel 
clinics, by month, 2008-2012 (n=48) (Dengue cases in Brazil, Ministry of Health.  Available at 
http://dtr2004.saude.gov.br/sinanweb/tabnet/dh?sinannet/dengue/bases/denguebrnet.def). 
Figure 3. Cutaneous larva migrans: a 26year-old male returned from Jamaica with a severely 
pruritic serpiginous rash. 
 
Figure 4. Myiasis: 50-year-old man returned from Belize feeling intermittent stabbing pain and 
movement within his arm lesions. 
 
Figure 5. Tungiasis: 21-year-old woman returned from Peru with painful nodules on her toes. 
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Table 1: Demographic and trip characteristics of ill returned travelers exposed in Brazil seen at 
GeoSentinel clinics, July 1997 – May 2013, N=1586 
Characteristic Brazil 
 
 n (%) 
Male 875 (55) 
Age (years)  
Median, range 33 (0-78) 
<15 83 (5) 
15-54 1306 (83) 
≥55 193 (12) 
Sought pre-travel advice  
Yes 755 (50) 
No 519 (35) 
Don’t know 226 (15) 
Expatriate 134 (9) 
Travel reason  
Tourism 1030 (65) 
VFR* 137 (9) 
Business 190 (12) 
Volunteer** 201 (13) 
Student 24 (2) 
Medical Tourism# 1 (<1) 
Hospitalization 116 (7) 
Trip duration¥  
<30 days 842 (59) 
≥30 days 579 (41) 
 
* VFR:  visiting friends and family. 
** Category includes missionary/volunteer/researcher/aid worker 
# Medical Tourism: the primary purpose of the travel was to seek medical care and the person developed a 
health problem as a consequence of this particular travel. 
¥ Trip duration calculated based on total trip, including travel to countries other than Brazil.  
£ Missing values: age (4), pre-travel advice (86), travel reason (3), hospitalization (6), trip duration (165)  
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Table 2: Top syndrome groups and top diagnoses* of ill returned travelers exposed in Brazil seen at 
GeoSentinel clinics, July 1997 – May 2013, N=1586  
 Brazil 
 
 
n % 
1 Dermatologic syndromes 630 40 
 Cutaneous larva migrans, hookworm-related 167 27 
 Bite, insect€  99 16 
 Skin and soft tissue infection¥ 92 15 
 Rash, unknown etiology (non-febrile) 43 7 
 Myiasis 37 6 
 Tungiasis 35 6 
 Fungal infection (superficial/cutaneous 
mycosis) 
26 4 
 Rabies, post exposure prophylaxis 17 3 
 Leishmaniasis, cutaneous 13 2 
2 Diarrheal syndromes  395 25 
 Acute diarrhea, etiology unknown£  146 37 
 Diarrhea, chronic unknown 70 18 
 Giardiasis 37 9 
 Campylobacter infection 14 4 
3 Febrile syndromes 297 19 
 Unspecified febrile illnessπ  109 37 
 Dengue 92 31 
 Malaria** 25 8 
 Epstein-Barr Virus infection/mononucleosis 17 6 
 Influenza-like illness  17 6 
 
 
* ≥1 diagnosis possible for each ill-returned traveler 
€Includes: Bite, insect (includes sting); Bite, insect, suprainfected 
¥ Includes: Skin and soft tissue infection; Skin and soft tissue infection, secondary bacterial of existing 
lesion; Skin and soft tissue infection, superficial skin abscess 
£ Includes: Diarrhea, acute bacterial; Diarrhea, acute unspecified; gastroenteritis 
π Includes: Febrile illness unspecified (< 3 weeks); Viral syndrome (no rash). 
**Includes: P. falciparum; P. vivax (n=20); Species unknown 
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Table 3. Frequency of top 5 specific diagnoses of ill returned travelers exposed in Brazil seen at 
GeoSentinel clinics, by month, June-September. 
June July August September 
CLM¥ 15 CLM¥ 20 Acute diarrhea, 
etiology unknown£ 
15 CLM¥ 11 
Acute diarrhea, 
etiology unknown£ 
10 PI-IBS¥ 8 Febrile unspecified <3 
weeks 
7 Viral syndrome (no 
rash) 
10 
Dengue 6 Acute diarrhea, 
etiology unknown£ 
8 PI-IBS¥ 7 Diarrhea, chronic 
unknown 
9 
Strongyloides 5 Giardia 6 Insect bites and stings 6 Acute diarrhea, 
etiology unknown£ 
7 
URI¥ 5 Unknown non-febrile 
rash 
5 CLM¥ 6 Tungiasis, Dengue* 5 
¥ CLM = Cutaneous larva migrans, hookworm-related; URI = Upper respiratory tract infection; 
PI-IBS = Irritable bowel syndrome, post-infectious. 
£ Acute diarrhea, etiology unknown: Diarrhea, acute bacterial; Diarrhea, acute unspecified; 
gastroenteritis. 
* There were 5 cases for each diagnosis. 
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Box. Recommended preparations for travelers planning to attend FIFA World Cup or Olympics 
in Brazil. 
All travelers should be up-to-date on their routine vaccines;in particular 
document receipt of vaccination for: 
 Hepatitis A 
 Influenza  
 Measles, mumps rubella. 
Advise travelers on specific risks: 
 Dengue prevention and other vector avoidance measures 
 Traveler’s diarrhea prevention and self management 
 Skin disorder precautions  
Review needs based  on specific travel destination: 
 Yellow fever vaccine 
 Malaria chemoprophylaxis 
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